Prostaglandin e2 modulation and uses thereof

Details Prostaglandin e2 modulation and uses thereof Prostaglandin e2 modulation and uses thereof

A - Human Necessities

61

K

A61K 31/616 (2006.01) A61K 31/7105 (2006.01) A61K 48/00 (2006.01) A61P 21/00 (2006.01) C12Q 1/02 (2006.01) C12Q 1/26 (2006.01) C12Q 1/68 (2006.01) G01N 33/88 (2006.01)

Patent

CA 2639412

Methods, uses, kits and products are described for the prognosis, diagnosis, prevention and treatment of myotronic dystrophy type 1 (DM1), and more particularly for the prognosis, diagnosis, prevention and treatment of the congenital form of myotronic dystrophy type 1 (cDM1), based on changes in/modulation of prostaglandin E2 (PGE2).

Affiliated with

Also associated with

Rating

Prostaglandin e2 modulation and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostaglandin e2 modulation and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin e2 modulation and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1693964